NCT04272086View on ClinicalTrials.gov

Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy

PHASE4RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

November 9, 2020

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Fibroid Uterus
Interventions
DRUG

Bupivacaine

0.25%

DRUG

Bupivacaine liposome

10mL

DRUG

normal saline

10ml

Trial Locations (1)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER